AR040889A1 - Agonistas muscarinicos - Google Patents
Agonistas muscarinicosInfo
- Publication number
- AR040889A1 AR040889A1 AR20030103011A ARP030103011A AR040889A1 AR 040889 A1 AR040889 A1 AR 040889A1 AR 20030103011 A AR20030103011 A AR 20030103011A AR P030103011 A ARP030103011 A AR P030103011A AR 040889 A1 AR040889 A1 AR 040889A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedures
- manufacture
- useful
- muscarinic agonists
- muscarnic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040889A1 true AR040889A1 (es) | 2005-04-20 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030103011A AR040889A1 (es) | 2002-08-22 | 2003-08-20 | Agonistas muscarinicos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (el) |
| EP (1) | EP1534667B1 (el) |
| JP (1) | JP4469280B2 (el) |
| CN (1) | CN100554247C (el) |
| AR (1) | AR040889A1 (el) |
| AT (1) | ATE491683T1 (el) |
| AU (1) | AU2003256791B2 (el) |
| BR (1) | BR0313161A (el) |
| CA (1) | CA2493958C (el) |
| CY (1) | CY1111115T1 (el) |
| DE (1) | DE60335380D1 (el) |
| DK (1) | DK1534667T3 (el) |
| ES (1) | ES2355213T3 (el) |
| MX (1) | MXPA05002080A (el) |
| PE (1) | PE20040894A1 (el) |
| PT (1) | PT1534667E (el) |
| SI (1) | SI1534667T1 (el) |
| TW (1) | TW200410922A (el) |
| WO (1) | WO2004018411A1 (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2620333A1 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| US20130029846A1 (en) | 2010-03-29 | 2013-01-31 | Basf Se | Fungicidal Iminoderivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0212353A (pt) * | 2001-09-21 | 2004-07-27 | Lilly Co Eli | Composto, composição farmacêutica, e, uso de um composto |
-
2003
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en active Application Filing
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60335380D1 (de) | 2011-01-27 |
| CY1111115T1 (el) | 2015-06-11 |
| AU2003256791A1 (en) | 2004-03-11 |
| EP1534667A1 (en) | 2005-06-01 |
| DK1534667T3 (da) | 2011-02-14 |
| WO2004018411A1 (en) | 2004-03-04 |
| SI1534667T1 (sl) | 2011-02-28 |
| US7160922B2 (en) | 2007-01-09 |
| EP1534667B1 (en) | 2010-12-15 |
| JP2005536549A (ja) | 2005-12-02 |
| JP4469280B2 (ja) | 2010-05-26 |
| PT1534667E (pt) | 2011-01-19 |
| AU2003256791B2 (en) | 2008-12-11 |
| TW200410922A (en) | 2004-07-01 |
| US20060122280A1 (en) | 2006-06-08 |
| CA2493958C (en) | 2010-11-09 |
| CN1675173A (zh) | 2005-09-28 |
| MXPA05002080A (es) | 2005-08-18 |
| CA2493958A1 (en) | 2004-03-04 |
| ES2355213T3 (es) | 2011-03-23 |
| PE20040894A1 (es) | 2004-11-25 |
| BR0313161A (pt) | 2005-06-14 |
| CN100554247C (zh) | 2009-10-28 |
| ATE491683T1 (de) | 2011-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
| MX2007007220A (es) | Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos. | |
| PA8609701A1 (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
| AR055123A1 (es) | Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta, composicion farmaceutica que la contiene y su aplicacin en terapeutica | |
| TW200531679A (en) | Methods of modulating cytokine activity; related reagents | |
| ECSP077985A (es) | Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina | |
| BR0208179A (pt) | Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto | |
| BRPI0511695A (pt) | agonistas de receptor (beta)2 adrenérgico diamina | |
| UY27976A1 (es) | Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia | |
| BRPI0409173A (pt) | compostos e composições como inibidores de proteìna quinase | |
| CR8522A (es) | Antagonistas del receptor hidroisoindolina taquiquinina | |
| TW200800959A (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor | |
| CO6351782A2 (es) | COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINA | |
| BRPI0415769A (pt) | alcanaminas de diidrobenzofuranila e composições farmacêuticas contendo-as | |
| PA8597301A1 (es) | Derivados de imidazol-4-il-etinil-piridina | |
| GT200800227A (es) | Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos | |
| WO2005030678A3 (en) | AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS | |
| DE60313004D1 (de) | Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination | |
| HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
| BR0211561A (pt) | Compostos e composições de 5-arilsulfonil indóis tendo afinidade para receptor 5-ht6 e seus usos | |
| DOP2006000145A (es) | Derivados de pirido [20,3-d] pirimidina su preparación, aplicación en terapeútica . | |
| CL2003001360A1 (es) | Compuestos derivados de pirazol, composicion farmaceutica, agonistas o antagonistas selectivos dl receptor cck-1, utiles para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. | |
| AR040889A1 (es) | Agonistas muscarinicos | |
| AR056279A1 (es) | Derivados de aril 1,4- pirazina sustituidos, composicion farmaceutica y un metodo in vitro | |
| AR045875A1 (es) | Procedimiento para la preparacion del antagonista ccr-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |